0001209191-20-062948.txt : 20201211 0001209191-20-062948.hdr.sgml : 20201211 20201211163530 ACCESSION NUMBER: 0001209191-20-062948 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201209 FILED AS OF DATE: 20201211 DATE AS OF CHANGE: 20201211 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MEDEL ROGER MD CENTRAL INDEX KEY: 0001093125 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12111 FILM NUMBER: 201383912 MAIL ADDRESS: STREET 1: 1301 CONCORD TERRACE CITY: SUNRISE STATE: FL ZIP: 33323 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MEDNAX, INC. CENTRAL INDEX KEY: 0000893949 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOSPITALS [8060] IRS NUMBER: 263667538 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1301 CONCORD TERRACE CITY: SUNRISE STATE: FL ZIP: 33323 BUSINESS PHONE: 9543840175 MAIL ADDRESS: STREET 1: 1301 CONCORD TERRACE CITY: SUNRISE STATE: FL ZIP: 33323 FORMER COMPANY: FORMER CONFORMED NAME: PEDIATRIX MEDICAL GROUP INC DATE OF NAME CHANGE: 19950801 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-12-09 0 0000893949 MEDNAX, INC. MD 0001093125 MEDEL ROGER MD 1301 CONCORD TERRACE SUNRISE FL 33323 1 0 0 0 Common Stock 2015-07-20 5 G 0 E 12735 0.00 D 1691877 D Common Stock 2015-07-24 5 G 0 E 1645 0.00 D 1690232 D Common Stock 2020-12-09 4 S 0 66806 23.002 D 1623426 D Common Stock 2020-12-10 4 S 0 33194 23.0439 D 1590232 D Reflects a gift of 12,735 shares of Common Stock made by the Reporting Person on July 20, 2015 that was not previously reported. Reflects a gift of 1,645 shares of Common Stock made by the Reporting Person on July 24, 2015 that was not previously reported. Sales made pursuant to Reporting Person's 10b5-1 trading plan adopted on August 13, 2020. The price reported in Column 4 is a weighted average price. These shares were sold in eight separate transactions with prices ranging from $23.00 to $23.04 for an average weighted sale price of $23.002. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote 4. The price reported in Column 4 is a weighted average price. These shares were sold in twenty-seven (27) separate transactions with prices ranging from $23.00 to $23.15 for an average weighted sale price of $23.0439. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote 5. /s/ Dominic J. Andreano, Attorney-in-Fact 2020-12-11